The OCT2/SLC22A2 protein and mRNA expression was found to be higher in clear cell renal carcinoma and lower in hepatocellular carcinoma as compared to non-cancerous tissues [70,75]. Here, SLC22A2 is linked to clear cell renal carcinoma.